Haifa company granted US patent for skeletal muscle regeneration
The patent was granted for the use of mesenchymal stem cells in skeletal muscle regeneration either directly after, or shortly after post-surgical muscle injury.
PLURISTEM CHAIRMAN AND CO-CEO Zami Aberman holds a vial of specialized stem cells the company calls ‘the next generation of biological therapeutic products.’(photo credit: COURTESY PLURISTEM)ByMAAYAN HOFFMAN
